HRASLS2 |
4.227 |
0.0368 |
lipid catabolism, phosphatidylethanolamine acyl-chain remodeling |
ISG15 |
3.676 |
0.0082 |
type I interferon signaling, response to virus |
IFI6 |
3.496 |
0.0002 |
type I interferon signaling, immune response |
IFIT1B |
3.492 |
0.0197 |
defense response to virus |
MX1 |
3.458 |
0.0042 |
type I interferon signaling, response to virus, innate immune response |
Saa3 |
3.290 |
0.0400 |
acute-phase response, I-kappaB phosphorylation, cell chemotaxis |
OAS1 |
3.266 |
0.0031 |
type I interferon signaling, response to virus, glucose homeostasis |
IFIT1 |
3.163 |
0.0079 |
type I interferon signaling, response to virus |
SAA1 |
3.031 |
0.0370 |
acute-phase response, innate immune activation, macrophage chemotaxis |
OASL |
2.900 |
0.0021 |
type I interferon signaling, response to virus |
HERC6 |
2.629 |
0.0059 |
protein polyubiquitination |
IFIT3 |
2.559 |
0.0016 |
type I interferon signaling, response to virus |
CMPK2 |
2.486 |
0.0048 |
cellular response to LPS, terminal differentiation of monocytic cells |
IRF7 |
2.417 |
0.0246 |
regulation of type I interferon production, innate immune response, defense response to virus |
EPSTI1 |
2.403 |
0.0014 |
nuclear translocation of NF-kappaB |
OAS2 |
2.332 |
0.0025 |
type I interferon signaling, response to virus |
H2-M2 |
2.308 |
0.00002 |
antigen processing and presentation via MHC class I |
LBP |
2.264 |
0.0033 |
acute-phase response, cellular response to LPS and lipoteichoic acid, macrophage activation |
HLA-G |
2.261 |
0.000007 |
antigen processing and presentation via MHC class I, regulation of tolerance induction |
MX2 |
2.229 |
0.0043 |
type I interferon signaling, response to virus |